Success of Dailies Total1 for Astigmatism Contact Lenses in Patients That Have Previously Failed With Toric Contact Lenses
1 other identifier
observational
65
1 country
1
Brief Summary
The objective is to determine the percentages of past toric CL wearers (who dropped out of contact lens wear due to dissatisfaction with comfort or vision) who are satisfied with the comfort and vision of DT1fA contact lenses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2023
CompletedFirst Posted
Study publicly available on registry
June 2, 2023
CompletedStudy Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedResults Posted
Study results publicly available
March 25, 2025
CompletedMarch 25, 2025
March 1, 2025
8 months
May 23, 2023
March 4, 2025
March 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of Patients With Positive Ratings (>50 Out of 100) for Satisfaction of Comfort and Vision.
A questionnaire will be administered. Subjects are asked to rate their satisfaction with comfort and vision on a scale of 0 to 100, with higher ratings indicating higher satisfaction with comfort and vision.
After 30 days of DT1fA contact lens wear
Other Outcomes (2)
Percentage of Patients Reporting Satisfaction of Overall and End of Day (EOD) Comfort and Vision; Comfort and Vision Under Real-world Conditions Related to Computer (or Tablet) Usage and Cellphone Usage.
After 30 days of DT1fA contact lens wear
Percentage of Patients Reporting a Desire to Remain in DT1fA Lenses After Study is Concluded.
After 30 days of DT1fA contact lens wear
Study Arms (1)
DT1fA contact lenses
Subjects fitted with DT1fA contact lenses
Interventions
Eligibility Criteria
Eligible test subjects will be 18 to 39 years of age with history of previous unsuccessful astigmatism contact lens wear.
You may qualify if:
- Subjects are eligible for the study if they meet the following criteria:
- Note: Ocular criteria must be met in both eyes.
- Gender: Males and Females.
- Subjects will be 18-39 years old.
- History of previous unsuccessful astigmatism contact lens wearer with qualifying answer to screening questions:
- I used to wear astigmatism correcting (toric) soft contact lenses.
- \- (YES)
- I stopped wearing my previous astigmatism correcting soft contact lenses because of one or more of the below reasons:
- Poor or fluctuating vision
- Discomfort
- Other
- Subjects must have 20/25 or better distance visual acuity in each eye with current best correction.
- Good general health (defined by prescription medication use that has not changed within the last month and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the PI).
- Ability to give informed consent.
- Willing and able to spend time for the study (Subjects will be required to attend three study visits and wear contact lenses on days between study visits).
You may not qualify if:
- Previous ocular surgery.
- Inability to be fit with the DT1fA lens design.
- Subjects that should be wearing a toric contact lens for best acuity but have chosen to continue in spherical contact lens wear.
- History of Accutane use.
- Ocular surface disease that in the investigator's opinion would interfere with contact lens wear.
- History of comorbidities, including autoimmune disorders and diabetes.
- Irregular astigmatism as identified by Pentacam.
- History of Amblyopia.
- History of Strabismus and/or history of eye muscle surgery.
- History of Monovision.
- Potential subjects who are pregnant.
- The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.
- Pregnancy has a known effect on the stability of refractions and visual acuity. As such, subjects who become pregnant during the study will not be discontinued but their data may be excluded from analyses of effectiveness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mann Eye Institutelead
- Sengicollaborator
Study Sites (1)
Mann Eye Institute
Houston, Texas, 76134-2099, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Phillip Brunson
- Organization
- Mann Eye Institute
Study Officials
- PRINCIPAL INVESTIGATOR
Phillip Brunson, OD
Mann Eye Institute
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2023
First Posted
June 2, 2023
Study Start
August 1, 2023
Primary Completion
April 1, 2024
Study Completion
April 1, 2024
Last Updated
March 25, 2025
Results First Posted
March 25, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share